GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,708.60p
   
  • Change Today:
      3.40p
  • 52 Week High: 1,713.00
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 7,547,306
  • Market Cap: £70,819m
  • RiskGrade: 129

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
16-Feb-24 Sell Emma Walmsley 1,657.97p 139,792 £2,317,709.49
24-Aug-23 Sell Hal Barron 3,461.74p 58,157 £2,013,244.20
24-Aug-23 Sell Hal Barron 3,461.74p 19,446 £673,169.98
23-Jun-23 Buy Julie Brown 1,429.13p 22,500 £321,554.25
01-Feb-24 Buy Julie Brown 1,582.80p 19,360 £306,430.08
22-Feb-24 Buy Hal Barron 1,737.62p 5,547 £96,385.75
18-May-23 Buy Hal Barron 1,760.50p 5,542 £97,566.91
23-Jun-23 Buy Jonathan Symonds 1,439.79p 6,000 £86,387.40
17-Aug-23 Buy Dividends Hal Barron 2,734.98p 2,919 £79,830.71
18-Apr-23 Buy Emma Walmsley 1,493.23p 5,618 £83,889.66
16-Nov-23 Buy Dividends Hal Barron 1,387.09p 5,606 £77,760.14
16-Jan-24 Buy Dividends Hal Barron 2,002.20p 3,947 £79,026.83
15-Jan-24 Buy Dividends Emma Walmsley 1,556.40p 4,947 £76,999.84
16-Oct-23 Buy Dividends Emma Walmsley 1,519.80p 5,020 £76,297.02
20-Jun-23 Buy Charles Bancroft 3,474.03p 1,646 £57,182.53
20-Mar-24 Buy Charles Bancroft 1,638.72p 3,306 £54,176.05
01-Feb-24 Buy Jonathan Symonds 1,570.62p 3,500 £54,971.70
20-Dec-23 Buy Charles Bancroft 2,897.38p 1,757 £50,906.88
20-Sep-23 Buy Charles Bancroft 1,540.17p 3,382 £52,088.46
20-Mar-24 Buy Jonathan Symonds 1,659.89p 2,900 £48,136.81

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,708.60p
Change Today 3.40p
% Change 0.20 %
52 Week High 1,713.00
52 Week Low 1,316.00
Volume 7,547,306
Shares Issued 4,144.88m
Market Cap £70,819m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.07% below the market average83.07% below the market average83.07% below the market average83.07% below the market average83.07% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Price Trend
50.74% above the market average50.74% above the market average50.74% above the market average50.74% above the market average50.74% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
31.40% above the market average31.40% above the market average31.40% above the market average31.40% above the market average31.40% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

What The Brokers Say

Strong Buy 7
Buy 6
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 28-Mar-2024

Time Volume / Share Price
17:14 750,000 @ 1,709.81p
17:04 13,917 @ 1,706.01p
17:04 13,076 @ 1,706.01p
17:04 549 @ 1,706.01p
17:03 172,458 @ 1,706.01p

GSK Key Personnel

CEO Emma Walmsley

Top of Page